AGT and acute kidney injury: Growing evidence suggests that locally produced intrarenal angiotensin II, a key effector peptide of RAAS, might contribute to AKI by increasing the expression of pro-inflammatory and pro-fibrotic cytokines and thereby modulating local inflammation [30,31].